PLEKHA5-L had the potential for melanoma migration and proliferation by upregulating oncogenes such as HRAS, AKT3 etc. PLEKHA5-L also upregulated expression of PD-L1and ABC transporters that were associated to therapy resistant. This evidence concerns the gene ABCG2 and melanoma.